Compounds > cholest-5-ene-3,4-diol
Page last updated: 2024-08-25

cholest-5-ene-3,4-diol and Polycystic Ovarian Syndrome

cholest-5-ene-3,4-diol has been researched along with Polycystic Ovarian Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hukkanen, J; Hyötyläinen, T; Morin-Papunen, L; Orešič, M; Piltonen, T; Puurunen, J; Ruokonen, A; Savolainen, MJ; Tapanainen, JS1

Trials

1 trial(s) available for cholest-5-ene-3,4-diol and Polycystic Ovarian Syndrome

ArticleYear
The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.
    British journal of clinical pharmacology, 2015, Volume: 80, Issue:3

    Topics: Adult; Atorvastatin; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Female; Humans; Hydroxycholesterols; Middle Aged; Polycystic Ovary Syndrome

2015